HYPERBILIRUBINEMIA Fatima C. Dela Cruz. Jaundice Yellowish discoloration of the skin, sclera and...
-
Upload
sophie-lawson -
Category
Documents
-
view
215 -
download
3
Transcript of HYPERBILIRUBINEMIA Fatima C. Dela Cruz. Jaundice Yellowish discoloration of the skin, sclera and...
HYPERBILIRUBINEMIA
Fatima C. Dela Cruz
Jaundice
Yellowish discoloration of the skin, sclera and other mucous membranes of the body
Jaundice
Accumulation in skin of unconjugated, non-polar, lipid-soluble bilirubin pigment formed from Hgb by the action of heme oxygenase, biliverdin reductase, & non-enzymatic reducing agents in the reticuloendothelial cells
Deposition of the pigment after it has been converted in the liver cell microsome by the enzyme uridine diphosphoglucuronic acid (UDP)-glucuronyl transferase to the polar, water-soluble ester glucuronide of bilirubin (direct reacting)
Jaundice
Face (total serum bilirubin ~ 5mg/dl) Midabdomen (TSB ~15 mg/dl) Feet (TSB ~20mg/dl)
Jaundice
Dermal Zones of Jaundice (Kramer, 1969)
Zone Range of TSB (mg/dL)
1 4.3 – 7.92 5.4 – 12.23 8.1 – 16.54 11.1 – 18.35 >15
Bilirubin
Macrophages Bloodstream Liver Gut
RBCs Heme Unconjugated Unconjugated bilirubin- Conjugated Urobilinogen
bilirubin albumin complex bilirubin
----------------------------------------------
-----------------------
Albumin
Indirect Bilirubin Direct bilirubin
Uridine
Glucuronyl transferase
80% -feces20% 10%-urine 90%-liver
Jaundice
Unconjugated hyperbilirubinemia is bright yellow or orange
Direct hyperbilirunemia is greenish or muddy yellow
Differential Diagnoses
Jaundice appearing at birth <24 hours Sepsis Erythroblastosis fetalis Concealed hemorrhage Cytomegalic inclusion disease Rubella Congenital toxoplasmosis
Differential Diagnoses
Jaundice appearing on the 2nd or 3rd day Physiologic hyperbilirubinemia of the
newborn Criggler-Najjar syndrome (familial
nonhemolytic icterus)
Differential Diagnoses
Jaundice appearing after the 3rd day, within the 1st week
Septicemia Syphilis Toxoplasmosis Cytomegalic inclusion disease Other causes of early jaundice
(Intrauterine transfusions, Extensive ecchymosis or hematomas, Polycythemia)
Differential Diagnoses
Jaundice appearing after the 1st week Breast milk jaundice Septicemia Congenital atresia of the bile ducts Hepatitis Rubella Galactosemia, hypothyroidism Spherocytosis (congenital hemolytic
anemia) Other hemolytic anemias (G6PD deficiency,
Glutathione synthetase deficiency, Peroxidase deficiency, Pyruvate kinase deficiency)
Physiologic Jaundice
Result of increased bilirubin production following breakdown of fetal red blood cells and limitation of liver bilirubin conjugation
Indirect bilirubin: 1-3 mg/dL; rises at a rate <5mg/dL/24h
Usually visible by the 2nd-3rd day and disappears by the 5th-7th day
Pathologic Jaundice
Jaundice appears in the first 24-36 h of life
Total serum bilirubin (TSB) rises by > 5 mg/dL/day
Serum bilirubin >12 mg/dL term and 10-14 mg/dL in preterm infants
Jaundice persists after 10-14 days of life Direct-reacting bilirubin >2 mg/dL at any
time
Pathologic Jaundice
1. Hemolytic disease Rh incompatibility ABO incompatibility Drugs (vitamin K) Congenital
hypothyroidism Increased hemolysis Cephal hematoma
2. Hepatocellular injury Biliary atresia Cholestasis Hepatitis Infection
3. Mixed hemolytic and hepatotoxic factors Infection (bacterial
and viral)
4. Hyperbilirubinemia secondary to metabolic factors Hypoxia Respiratory distress Hypoglycemia Hypothyroidism
Breastfeeding Jaundice
bilirubin during the first week of life in breastfed infants due to both caloric and fluid deprivation
Resolves with increased breast feeding frequency and amount of milk intake
Breastmilk Jaundice
Jaundice among breastfed infants probably secondary to hormones (pregnanediol) in milk acting on infant’s hepatic metabolism and an enzyme (glucuronidase) facilitating intestinal reabsorption of bilirubin
Treatment
Phototherapy Exchange transfusion Intravenous immunoglobulin Metalloporphyrins
Treatment
Phototherapy Exposure to a high intensity of light in the visible
spectrum Bilirubin absorbs light maximally in the blue range Photoisomerization
converts unconjugated bilirubin (4Z, 15Z) into unconjugated isomer (4Z, 15E) which is excreted in the bile
Structural change converts unconjugated bilirubin to lumirubin, which is
excreted in the urine in an unconjugated state
Treatment
Exchange transfusion Partial removal of the infant’s circulating
antibody coated RBCs as well as unattached antibodies and replace